Matinas Biopharma Terminates Agreement With Former Financial Advisor On Nov 3, 2026

On November 3, 2026, Matinas BioPharma Holdings, Inc. (the "Company") and a former financial advisor to the Company (the "Advisor") terminated the agreement between the Company and the Advisor. That agreement provided for, among other things, the payment to the Advisor of up to $2.0 million in cash and up to $2.0 million in stock in connection with the closing of certain business combinations. In connection with the termination, the Company paid the Advisor $562,500 in cash, and the Company and the Advisor exchanged mutual releases, subject to certain contingencies.